
DeepCure raised $24 million in Series A-1 funding
DeepCure recently secured $24 million in a Series A-1 funding round led by IAG Capital Partners and backed by its existing investors. DeepCure seeks to leverage its Molecular Foundry to shorten the times for the drug development cycle without sacrificing novelty and diversity.